Addex Therapeutics (ADXN) Common Equity (2018 - 2026)
Addex Therapeutics (ADXN) posted Common Equity of $4.2 million for Q1 2026, down 29.63% sequentially from $6.0 million in Q4 2025, and down 54.51% YoY from $9.2 million in Q1 2025.
Addex Therapeutics (ADXN) Common Equity (2018 - 2026) Analysis & Trends
Addex Therapeutics has reported Common Equity for 9 years, with the latest figure at $4.2 million in Q1 2026.
- Quarterly Common Equity fell 54.51% year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (down 54.51% YoY) and the FY2025 annual result came in at $5.7 million, down 47.73% from the prior year.
- Common Equity eased to $4.2 million in Q1 2026 per ADXN's latest filing, from $6.0 million in the prior quarter.
- Over five years, Common Equity peaked at $14.0 million in Q1 2022 and troughed at -$1.6 million in Q1 2024.
- A 5-year average of $7.2 million and a median of $7.1 million in 2022 frame the typical range for Common Equity.
- The widest YoY moves for Common Equity: up 755.45% in 2024, down 135.74% in 2024.
- Over 5 years, Common Equity stood at $5.1 million in 2022, then plunged by 74.68% to $1.3 million in 2023, then jumped by 755.45% to $11.0 million in 2024, then plunged by 46.01% to $6.0 million in 2025, then slipped by 29.63% to $4.2 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $4.2 million, $6.0 million, and $7.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.35 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 22.38 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 757.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.79 Bn |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - | 4.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.20 Mn |
| Dec 31, 2025 | 5.96 Mn |
| Sep 30, 2025 | 7.45 Mn |
| Jun 30, 2025 | 8.71 Mn |
| Mar 31, 2025 | 9.23 Mn |
| Dec 31, 2024 | 11.05 Mn |
| Sep 30, 2024 | 12.77 Mn |
| Jun 30, 2024 | 13.99 Mn |
| Mar 31, 2024 | -1.57 Mn |
| Dec 31, 2023 | 1.29 Mn |
| Sep 30, 2023 | 4.47 Mn |
| Jun 30, 2023 | 6.81 Mn |
| Mar 31, 2023 | 4.40 Mn |
| Dec 31, 2022 | 5.10 Mn |
| Sep 30, 2022 | 8.23 Mn |
| Jun 30, 2022 | 7.13 Mn |
| Mar 31, 2022 | 14.03 Mn |
| Dec 31, 2021 | 18.36 Mn |
| Sep 30, 2021 | 14.53 Mn |
| Jun 30, 2021 | 18.01 Mn |